Fig. 6From: LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndromeImpact of mean LEP promoter methylation above or below the cutoff of 51.03% in bone marrow MNCs from MDS patients (validation cohort) on A overall survival and B progression-free survival (PFS). MNC, mononuclear cells; MDS: myelodysplastic syndromeBack to article page